» Authors » Argonde van Harten

Argonde van Harten

Explore the profile of Argonde van Harten including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 73
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li W, Petersen R, Algeciras-Schimnich A, Cogswell P, Bornhorst J, Kremers W, et al.
Mayo Clin Proc . 2024 Jun; 99(8):1284-1296. PMID: 38935019
Objective: To evaluate the performance of Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers in a tertiary neurology clinic setting with high frequency of non-AD cases, including normal pressure hydrocephalus (NPH)....
2.
Tate A, Bouteloup V, van Maurik I, Jean D, Mank A, Speh A, et al.
Alzheimers Dement . 2023 Oct; 20(2):809-818. PMID: 37779086
Introduction: Inferring the timeline from mild cognitive impairment (MCI) to severe dementia is pivotal for patients, clinicians, and researchers. Literature is sparse and often contains few patients. We aim to...
3.
Graff-Radford J, Jones D, Wiste H, Cogswell P, Weigand S, Lowe V, et al.
Neurobiol Aging . 2021 Nov; 110:27-36. PMID: 34844077
Do MRI-based metrics of a CSF-dynamics disorder, disproportionately enlarged subarachnoid-space hydrocephalus (DESH), correlate with discordant amyloid biomarkers (low CSF β-amyloid 1-42, normal Aβ-PET scan)? Individuals ≥50 years from the Mayo...
4.
Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, et al.
J Alzheimers Dis . 2014 Apr; 41(3):801-7. PMID: 24705549
Background: Two approaches are available for measuring Alzheimer's disease (AD) pathology in vivo. Biomarkers in cerebrospinal fluid (CSF) include amyloid-β1-42 (Aβ42) and tau. Furthermore, amyloid deposition can be visualized using...